The vice-president of Robarts Research Institute is trying to put together a funding structure for Diabetogen, a biotechnology company, being spun off by the Institute.
He must assess the worth of the company, how the equity should be divided among its stakeholders, and how much of the business must be given up to first-round investors.
Publication Date: 05/09/2000
This is just an excerpt. This case is about Finance
Related Case Solutions & Analyses:
Investment Banking in 2008 (B): Brave New World
Thailand: An Imbalance of Payments
Powerwater Beverages
ExlService: Business Process Outsourcing in India
Samuel Slater Francis Cabot Lowell and the Beginnings of the Factory System in the United States
Red Star Furniture Group Co. LTD.
Jefferson County (C): Subsequent Issuance
1 > 2? Less Is More Under Volatile Exchange Rates In Global Supply Chains
Financing Structures in the Shipping Industry: Singapore’s Pacific Shipping Trust
Price or Relationship: SecureNow’s Dilemma
